Source: Resumos. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
NATHAN, L P et al. A-127722.5, an endothelin antagonist, reverses hypertension induced by chronic inhibition of nitric oxide synthesis. 1997, Anais.. São Paulo: FESBE, 1997. . Acesso em: 19 abr. 2024.APA
Nathan, L. P., Zappellini, A., Metze, K., Antunes, E., Zatz, R., & De Nucci, G. (1997). A-127722.5, an endothelin antagonist, reverses hypertension induced by chronic inhibition of nitric oxide synthesis. In Resumos. São Paulo: FESBE.NLM
Nathan LP, Zappellini A, Metze K, Antunes E, Zatz R, De Nucci G. A-127722.5, an endothelin antagonist, reverses hypertension induced by chronic inhibition of nitric oxide synthesis. Resumos. 1997 ;[citado 2024 abr. 19 ]Vancouver
Nathan LP, Zappellini A, Metze K, Antunes E, Zatz R, De Nucci G. A-127722.5, an endothelin antagonist, reverses hypertension induced by chronic inhibition of nitric oxide synthesis. Resumos. 1997 ;[citado 2024 abr. 19 ]